English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 January 2012, 09:00 HKT/SGT
Share:
    

Source: Pharma Regulatory Affairs
National Agency of Drug and Food Control, Indonesia Newly Confirmed Present at 2nd Annual Pharma Regulatory Affairs Asia

SINGAPORE, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.

Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.

Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.

In China, what's the impact of the healthcare system reform on pharma companies?

In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?

In Vietnam, what is the regulation framework for drug registration and product commercialisation?

In Indonesia, what are the new regulations related to pre-market evaluation?

The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.

Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.

Contact:
Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg


Topic: Press release summary
Source: Pharma Regulatory Affairs

Sectors: Trade Shows, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million  
Mar 8, 2025 19:40 HKT/SGT
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation  
Mar 8, 2025 19:20 HKT/SGT
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook  
Mar 7, 2025 20:26 HKT/SGT
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels  
Friday, March 7, 2025 3:24:00 PM
Giftify, Inc. Launches Sports Ticket & Merchandise Savings Platform as Fan Expenses Surge  
Mar 7, 2025 15:02 HKT/SGT
Doubleview Gold Corp Announces Collaboration with Her Excellency Sheikha Sara Nasser Al-Thani CEO of Qmission W.L.L. Qatar  
Mar 7, 2025 14:47 HKT/SGT
Singapore to Host the 24th Cyber Security Summit: Addressing Emerging Threats and AI-Driven Security  
Mar 7, 2025 14:40 HKT/SGT
Big Ideas, Bold Leaders: Big CIO Show and Awards is Where Business Meets Innovation  
Mar 7, 2025 12:19 HKT/SGT
Lizzies Countdown Is On  
Mar 7, 2025 09:00 HKT/SGT
Winvest Group's IQI Media Gears Up for Q2 Beta Demos of AI & Blockchain-Powered Streaming Distribution Platform  
Mar 6, 2025 21:30 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575